Sandoz $275,000,000 Generic Drugs Settlement, Check If You Qualify — In re Generic Pharmaceuticals Antitrust Litigation, No. 16-MD-2724

There’s a $275 million fund waiting for anyone who paid for certain generic prescription drugs between May 1, 2009, and December 31, 2019 — if you can show you paid for one of them. Sandoz Inc. and Fougera Pharmaceuticals Inc. agreed to the payout to settle claims they took part in a scheme to fix generic drug prices. You have until November 9, 2026, to file.

Who Are Sandoz and Fougera and Why Are They Being Sued for Price-Fixing?

Sandoz Inc. and its subsidiary Fougera Pharmaceuticals Inc. are indirect subsidiaries of the Swiss drugmaker Sandoz Group AG, one of the world’s largest generic and biosimilar medicine manufacturers. Because generics are supposed to compete on price once a brand-name patent expires, a manufacturer with real market share — like Sandoz — was specifically positioned to affect what millions of Americans paid at the pharmacy counter if it coordinated with rivals instead of competing against them.

What Did Sandoz Do to Generic Drug Buyers Between 2009 and 2019?

The lawsuit, consolidated as In re Generic Pharmaceuticals Antitrust Litigation in the Eastern District of Pennsylvania, claims Sandoz, Fougera, and a long list of other generic manufacturers violated federal and state antitrust laws, consumer protection statutes, and common law. The allegation: instead of undercutting each other on price for certain “Named Generic Drugs,” the companies coordinated pricing, which caused End-Payers — everyday consumers, along with insurers and employer health plans that reimbursed prescription costs — to pay more than they should have.

Sandoz denies it’s liable. No court has ruled on the merits, and the case is still active against the manufacturers that haven’t settled. What Sandoz agreed to do is put $275,000,000 into a settlement fund and cooperate with the remaining litigation by handing over information that could help the case against those other companies.

If you paid a copay, an out-of-pocket price, or had your insurer foot the bill for one of the covered generics during that decade, some of that fund is meant for you.

Read more: The EpiPen antitrust settlement followed a similar path from price-fixing allegations to a claims process, and it’s worth comparing how that one played out.

Sandoz Generic Drugs Settlement — Key Facts

Settlement Amount	$275,000,000
Claim Deadline	November 9, 2026
Who Qualifies	Consumers and third-party payers (insurers, employer or union health plans) who indirectly purchased, paid for, or reimbursed certain “Named Generic Drugs” for personal use, other than for resale, from May 1, 2009 through December 31, 2019, in the U.S. (except Indiana and Ohio), D.C., Puerto Rico, and the U.S. Virgin Islands
Estimated Payout	Pro rata — depends on how much you spent on covered drugs and how many valid claims are filed; no fixed amount
Proof Required (Yes/No)	UNVERIFIED — official notices confirm payment is based on documented amounts spent, but the specific claim-form proof standard was not independently confirmed from a named primary source as of this writing
Settlement Status	Final approval reached; claim forms are now being accepted
Court & Case Number	In re Generic Pharmaceuticals Antitrust Litigation, No. 16-MD-2724, U.S. District Court for the Eastern District of Pennsylvania
Law Alleged	Federal and state antitrust laws, consumer protection statutes, and common law
Administrator	A.B. Data, Ltd.
Official Claim Site	www.GenericDrugsEndPayerSettlement.com
Last Updated	September 22, 2026

Who Qualifies for the Sandoz Generic Drugs Settlement?

Here’s exactly how to know if this case includes you.

• Consumers who personally paid a copay, coinsurance, or out-of-pocket cost for a Named Generic Drug between May 1, 2009, and December 31, 2019
• Health insurers, employer health plans, or union benefit funds that reimbursed those drug costs during the same window
• People who bought a covered drug indirectly — meaning through a pharmacy, not directly from the manufacturer
• Anyone in any state except Indiana and Ohio, plus D.C., Puerto Rico, and the U.S. Virgin Islands

You do not qualify if you purchased a Named Generic Drug for resale rather than personal use, or if you bought directly from the manufacturer rather than through a pharmacy — that’s a separate, non-consumer settlement track.

Generic Drug Buyers Outside the Named 48 Jurisdictions — Are You Still Covered?

This settlement is nationwide, minus two states. If you’re in Indiana or Ohio, you’re excluded from this particular Sandoz settlement class — those states pursued separate legal tracks. Everyone else in the 50 states, D.C., Puerto Rico, and the U.S. Virgin Islands who otherwise qualifies is covered.

Not sure if you qualify for the Sandoz generic drugs settlement? A free consultation with a consumer protection attorney can help you sort out your eligibility before the November 9, 2026 deadline.

How Much Can Sandoz Generic Drugs Settlement Class Members Get?

There’s no set dollar figure per person — this is a pro rata settlement. What you’d receive depends on two things: how much you can document you spent on covered generic drugs during the class period, and how many other valid claims get filed against the same fund.

Before any money reaches class members, the fund covers costs of notice and administration (up to $750,000), attorneys’ fees (up to one-third of the fund, plus interest), litigation expenses (up to $26,000,000), and service awards to the class representatives (up to $500,000 combined). What’s left is distributed under a court-approved plan of allocation.

Payments over $600 may appear on a 1099. Check with a tax professional.

The $275 million from Sandoz isn’t standing alone, either. It’s now being processed together with two other final settlements in the same case — a $200 million deal with Sun Pharmaceutical and Taro Pharmaceuticals, and $58 million combined from Heritage Pharmaceuticals and Apotex — through one shared claims process on the same website, with the same November 9, 2026 deadline.

Here’s the part worth sitting with: the smaller your documented purchase history, the smaller your eventual check — so gathering every receipt or pharmacy record you can find before you file directly affects what you get back.

How to File Your Sandoz Generic Drugs Settlement Claim — Step by Step

1. Go to www.GenericDrugsEndPayerSettlement.com, the official settlement site.
2. Confirm which class you fall into — consumer or third-party payer — since the site handles each differently.
3. Gather documentation of what you spent on covered generic drugs between May 1, 2009, and December 31, 2019: pharmacy records, receipts, or insurance statements.
4. Fill in your purchase history as completely as the claim form requests.
5. Submit your claim online, or by mail if you prefer, and save your confirmation.
6. Watch your email or the settlement site for updates — the administrator, A.B. Data, Ltd., will post news on distribution timing once claims close.

⚠️ Under two months left — file at www.GenericDrugsEndPayerSettlement.com before November 9, 2026.

Should Sandoz Class Members Opt Out or Object Before the Deadline?

What Opting Out of the Sandoz Settlement Actually Means

The opt-out and objection windows have already closed for all three linked settlements — the Sandoz deadline was May 9, 2025; the Heritage/Apotex deadline was July 24, 2025; and the Sun/Taro deadline was December 2, 2025. If you did nothing by those dates, you’re automatically a class member now, bound by the settlement, and eligible to file a claim.

How to Object to the Sandoz Settlement

That window has passed too — the court already held its fairness hearings (July 23, 2025 for Sandoz, October 3, 2025 for Heritage/Apotex, and January 15, 2026 for Sun/Taro) and granted approval. At this point, filing a claim by November 9, 2026 is the action that’s actually still available to you.

Talk to a class action antitrust attorney if you have questions about how the approved settlement affects any related rights you may have.

Sandoz Generic Drugs Settlement — Key Dates, 2025–2026

Milestone	Date
Settlement Proposed (Sandoz/Fougera)	March 10, 2025
Opt-Out/Objection Deadline (Sandoz/Fougera)	May 9, 2025
Final Approval Hearing (Sandoz/Fougera)	July 23, 2025
Opt-Out/Objection Deadline (Heritage/Apotex)	July 24, 2025
Final Approval Hearing (Heritage/Apotex)	October 3, 2025
Opt-Out/Objection Deadline (Sun/Taro)	December 2, 2025
Final Approval Hearing (Sun/Taro)	January 15, 2026
Claims Period Opens (combined)	UNVERIFIED — exact claims-opening date not confirmed from a named primary source; claims were confirmed open as of the administrator’s most recent notice
Claim Filing Deadline (combined)	November 9, 2026
Expected Payment Date	UNVERIFIED — distribution timing has not been announced

Sandoz Generic Drugs Settlement — Frequently Asked Questions, No. 16-MD-2724

Do I need a lawyer to file a Sandoz generic drugs settlement claim?

 No. The claim form is designed for consumers and third-party payers to file directly at www.GenericDrugsEndPayerSettlement.com. A consumer protection attorney can help if your situation is complicated, but it’s not required.

Is the Sandoz generic drugs settlement legitimate?

 Yes. It’s part of In re Generic Pharmaceuticals Antitrust Litigation, No. 16-MD-2724, pending in the U.S. District Court for the Eastern District of Pennsylvania, and the notice was authorized by that federal court and issued by class counsel Fine, Kaplan and Black, R.P.C.

When will Sandoz settlement payments be sent?

 There’s no announced payment date yet. Distribution happens after the November 9, 2026 claim deadline closes and the court approves a final plan of allocation.

What if I missed the Sandoz claim deadline?

 There’s no deadline to miss yet — November 9, 2026 is still ahead. If that date passes without a claim from you, though, you won’t receive a payment from this settlement.

Will my Sandoz settlement payment go on a 1099?

 Possibly. Payments over $600 may be reported. Check with a tax professional about how a settlement payment affects your taxes.

Can I file a claim for both the Sandoz and Sun/Taro settlements?

 Yes, if you purchased qualifying drugs covered by both settlements. The claims process for Sandoz, Sun/Taro, and Heritage/Apotex has been combined on one site, with one November 9, 2026 deadline covering all three.

What if I’m not sure which generic drugs are covered?

 Check the official list of Named Generic Drugs posted at www.GenericDrugsEndPayerSettlement.com before you file, so you can gather the right purchase records.

Do I need proof of purchase to file a claim? 

The official notice indicates your payment is based on documented amounts spent on covered drugs, so keeping pharmacy records, receipts, or insurance statements on hand will help your claim — though the exact documentation standard required by the claim form has not been independently confirmed from a named primary source as of this writing.

Sources Used in This Sandoz Generic Drugs Settlement Article

• Official Settlement Administrator Website — Generic Drugs End-Payer Settlement: https://www.genericdrugsendpayersettlement.com/
• Official Law Firm Press Release — Fine, Kaplan, and Black, R.P.C., “$275 Million Class Action Settlement To Benefit Consumers and Third-Party Payers Announced by End-Payer Plaintiffs in Prescription Generic Drug Case,” PRNewswire, March 10, 2025: https://www.prnewswire.com/news-releases/275-million-class-action-settlement-to-benefit-consumers-and-third-party-payers-announced-by-end-payer-plaintiffs-in-prescription-generic-drug-case-302395189.html
• Official Law Firm Press Release — Fine, Kaplan and Black, R.P.C., “Fine, Kaplan and Black, R.P.C. Announce Class Action Settlements on Behalf of Those Who Paid and/or Reimbursed for Certain Prescription GENERIC Drugs,” PRNewswire, May 19, 2025: https://www.prnewswire.com/news-releases/fine-kaplan-and-black-rpc-announce-class-action-settlements-on-behalf-of-those-who-paid-andor-reimbursed-for-certain-prescription-generic-drugs-in-the-united-states-between-may-1-2009-and-december-31-2019-302459250.html
• Official Law Firm Press Release — Fine, Kaplan, and Black, R.P.C., PRNewswire, October 3, 2025 (Sun/Taro settlement notice): https://www.prnewswire.com/news-releases/fine-kaplan-and-black-rpc-announce-a-class-action-settlement-if-you-paid-or-reimbursed-for-certain-prescription-generic-drugs-in-the-united-states-between-may-1-2009-and-december-31-2019-302573078.html
• Official Law Firm Press Release — Fine, Kaplan and Black, R.P.C., “Fine, Kaplan and Black, R.P.C. Announces Claim Forms Now Being Accepted for Class Action Settlements,” PRNewswire, confirming the November 9, 2026 filing deadline: https://www.prnewswire.com/news-releases/fine-kaplan-and-black-rpc-announces-claim-forms-now-being-accepted-for-class-action-settlements-if-you-paid-or-reimbursed-for-certain-prescription-generic-drugs-in-the-united-states-between-may-1-2009-and-december-31-2019-302822284.html

 Researched and written by Israr Ahmad, legal content researcher and founder of AllAboutLawyer.com. All facts verified against official law firm press releases issued through PRNewswire by court-appointed class counsel Fine, Kaplan and Black, R.P.C., and against the official settlement administrator website, on September 22, 2026. Last Updated: September 22, 2026.

Disclaimer This article is for informational purposes only and does not constitute legal advice. Laws vary by state and individual circumstances differ. For advice about your specific situation, consult a qualified attorney.